Chronic Renal Insufficiency in NAPRTCS Patients

NAPRTCS 患者的慢性肾功能不全

基本信息

项目摘要

DESCRIPTION (provided by applicant): This application, a joint effort of 26 centers of the NAPRTCS, is entitled "Chronic Renal Insufficiency (CRI) in NAPRTCS Patients. We will enroll 300 children (1-16 years) with measured glomerular filtration rates (GFR) of 25-75 mL/min/1.73m2. Follow-up with annual GFR and 6 month physical examinations and determinations of hemoglobin, electrolytes, serum, albumin, serum calcium, serum phosphorus, parathyroid hormone and urinary indices will test the 1st hypothesis that this cohort will most accurately define the rate of and the risk factors for progression of CRI, and that this progression will be correlated with proteinuria, albumin, blood pressure, nutritional status, growth and hyperparathyroidism. To test the 2nd hypothesis that cardiovascular disease develops in children with mild CRI and that its prevalence and severity increase in association with the progression of CRI, we will perform baseline and annual 24-hour ambulatory blood pressure monitoring, echocardiographic assessments to determine left-ventricular mass and LV function, and B-mode ultrasound of the carotid artery to determine the IMT and carotid artery compliance. To test the 3rd hypothesis that the neurocognitive outcome of children with CRI is influenced by the progression of renal insufficiency, a battery of validated neurocognitive tests will be conducted at study entry and at 6, 12 and 24 months to assess many cortical and subcortical areas of brain function. To test the 4th hypothesis that chronic inflammation contributes to cachexia, growth hormone resistance and growth retardation, we will examine the impact of circulating cytokine and neuropeptide concentrations on dietary intake, nutritional and growth parameters as well as growth hormone axis pertubations and responsiveness to growth hormone therapy. Finally, to test the 5th hypothesis that a correlation exist between bone histology, serum concentration of PTH and measured GFR, we will measure and characterize the biochemical and histologic features of renal osteodystrophy and determine the serum concentrations of PTH that are associated with normal rates of bone formation.
描述(由申请人提供): 这项应用是NAPRTC的26个中心的共同努力,标题为“ NAPRTCS患者的慢性肾功能不全(CRI)。我们将招募300名儿童(1-16岁),测量的肾小球过滤率(GFR)为25-75 ml/1.73m2mm2。 serum, albumin, serum calcium, serum phosphorus, parathyroid hormone and urinary indices will test the 1st hypothesis that this cohort will most accurately define the rate of and the risk factors for progression of CRI, and that this progression will be correlated with proteinuria, albumin, blood pressure, nutritional status, growth and hyperparathyroidism. To test the 2nd hypothesis that cardiovascular disease患有轻度CRI的儿童的发展,其患病率和严重程度随CRI的发展相关性,我们将进行基线和年度24小时的卧床血压监测,超声心动图评估,以确定腹膜质量和LV功能,以及B模式超声,以确定IMT和Carotid Artery Artery Artery Arter Artery Artery。为了检验第三个假设,即CRI儿童的神经认知结果受肾功能不全的进展,在研究入学时将进行一系列经过验证的神经认知测试,并在6、12和24个月进行评估,以评估许多大脑功能的皮质和皮层皮质和亚皮层区域。为了检验第四个假设,即慢性炎症有助于恶病恶检查,生长激素抗性和生长迟缓,我们将研究循环细胞因子和神经肽浓度对饮食摄入,营养和生长参数以及生长激素轴承的影响以及对生长激素治疗的影响。最后,为了检验第五个假设,即骨骼组学,PTH的血清浓度和测量的GFR之间存在相关性,我们将测量和表征肾脏骨肌营养体的生化和组织学特征,并确定与正常骨形成率相关的PTH血清浓度。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bradley Alan Warady其他文献

Bradley Alan Warady的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bradley Alan Warady', 18)}}的其他基金

Chronic Kidney Disease in Children (CKiD)
儿童慢性肾脏病 (CKiD)
  • 批准号:
    7901931
  • 财政年份:
    2009
  • 资助金额:
    $ 42.47万
  • 项目类别:
Chronic Renal Insufficiency in NAPRTCS Patients
NAPRTCS 患者的慢性肾功能不全
  • 批准号:
    7289344
  • 财政年份:
    2003
  • 资助金额:
    $ 42.47万
  • 项目类别:
Chronic Kidney Disease in Children (CKiD)
儿童慢性肾脏病 (CKiD)
  • 批准号:
    7547453
  • 财政年份:
    2003
  • 资助金额:
    $ 42.47万
  • 项目类别:
Chronic Kidney Disease in Children (CKiD III)
儿童慢性肾脏病 (CKiD III)
  • 批准号:
    8728192
  • 财政年份:
    2003
  • 资助金额:
    $ 42.47万
  • 项目类别:
Chronic Kidney Disease in Children (CKiD IV)
儿童慢性肾脏病 (CKiD IV)
  • 批准号:
    9769697
  • 财政年份:
    2003
  • 资助金额:
    $ 42.47万
  • 项目类别:
Chronic Kidney Disease in Children (CKiD)
儿童慢性肾脏病 (CKiD)
  • 批准号:
    7681325
  • 财政年份:
    2003
  • 资助金额:
    $ 42.47万
  • 项目类别:
Chronic Kidney Disease in Children (CKiD V)
儿童慢性肾脏病 (CKiD V)
  • 批准号:
    10731013
  • 财政年份:
    2003
  • 资助金额:
    $ 42.47万
  • 项目类别:
Building capacity to guide disclosure of genomic research results in CKiD
建设指导 CKiD 基因组研究结果披露的能力
  • 批准号:
    10366290
  • 财政年份:
    2003
  • 资助金额:
    $ 42.47万
  • 项目类别:
Chronic Renal Insufficiency in NAPRTCS Patients
NAPRTCS 患者的慢性肾功能不全
  • 批准号:
    7124297
  • 财政年份:
    2003
  • 资助金额:
    $ 42.47万
  • 项目类别:
Chronic Kidney Disease in Children (CKiD III)
儿童慢性肾脏病 (CKiD III)
  • 批准号:
    8581783
  • 财政年份:
    2003
  • 资助金额:
    $ 42.47万
  • 项目类别:

相似国自然基金

用于胰腺癌光免疫协同治疗的单分子白蛋白纳米粒及其增敏机制研究
  • 批准号:
    32330060
  • 批准年份:
    2023
  • 资助金额:
    212 万元
  • 项目类别:
    重点项目
巯基介导的花色苷/豌豆白蛋白递送体系与肠道粘蛋白MUC2的粘附作用机制研究
  • 批准号:
    32372360
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
α-乳白蛋白姜黄素纳米复合物通过PepT1-溶酶体提高生物利用度对镉致动脉粥样硬化的干预作用机制研究
  • 批准号:
    82373600
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
小白蛋白调控巨噬细胞极化改善泌乳素瘤耐药的机制研究
  • 批准号:
    82373131
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
适配体修饰的白蛋白他汀纳米粒调控HER2胞内命运改善HER2阳性胃癌疗效的研究
  • 批准号:
    82304400
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Acute Kidney Injury in Children with Chronic Kidney Disease
慢性肾病儿童的急性肾损伤
  • 批准号:
    10638267
  • 财政年份:
    2023
  • 资助金额:
    $ 42.47万
  • 项目类别:
Machine Learning Risk Prediction of Kidney Disease After Extremely Preterm Birth
机器学习对极早产后肾脏疾病的风险预测
  • 批准号:
    10589356
  • 财政年份:
    2023
  • 资助金额:
    $ 42.47万
  • 项目类别:
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration
年龄相关性黄斑变性的新型抗炎治疗方法的评价
  • 批准号:
    10642988
  • 财政年份:
    2023
  • 资助金额:
    $ 42.47万
  • 项目类别:
Overcoming pressure ulcers with engineered hormones and stem cells
用工程激素和干细胞克服压疮
  • 批准号:
    10821146
  • 财政年份:
    2023
  • 资助金额:
    $ 42.47万
  • 项目类别:
Safety and Efficacy of Empagliflozin Main intenance HD (SEED)
Empagliflozin Main Intenance HD (SEED) 的安全性和功效
  • 批准号:
    10660436
  • 财政年份:
    2023
  • 资助金额:
    $ 42.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了